• Find people
• Intranet

News

• 16/12/2010 - General information

  25 years of the IMIM Anti-Doping Control Laboratory

  

  In November, the IMIM Anti-Doping Control Laboratory, directed by Dr. Jordi Segura, celebrated 25 years of history. Ever since it was first accredited by the International Olympic Committee in 1985, its objective has always been to offer high quality, reliable services. It is currently made up of a team of around 30 people from various disciplines and origins, all of whom have extensive experience in the doping field.

  Més informació "25 years of the IMIM Anti-Doping Control Laboratory"

• 13/12/2010 - General information

  The IMIM hosts the meeting of the Laboratory Committee of the World Anti-Doping Agency (WADA)

  

  In connection with this, the meeting of the WADA Lab Committee, chaired by Toni Pascual, took place in the IMIM on the 9th and 10th December past. This committee is made up of an international group of experts on doping and is the advisory body in charge of all aspects related to the work carried out by anti-doping control laboratories on a global scale

  Més informació "The IMIM hosts the meeting of the Laboratory Committee of the World Anti-Doping Agency (WADA)"

• 30/11/2010 - Institutional news

  Roberto Elosua wins the COMB Award for Professional Excellence

  

  The prize-giving ceremony for the Awards for Professional Excellence 2010, organised by the Barcelona College of Doctors (COMB), took place on the 29th November in the Teatro Romea. Roberto Elosua, coordinator of the IMIM Cardiovascular Genetics and Epidemiology Research Group, received an award at this year’s ceremony along with other professionals from MAR Health Park.

  Més informació "Roberto Elosua wins the COMB Award for Professional Excellence"

• 16/11/2010 - General information

  Important progress made on the human immune system’s ability to tackle cytomegalovirus

  

  A study directed by Miguel López-Botet, director of the IMIM (Hospital del Mar Research Institute) and coordinator of the Immunology Laboratory of the Health and Experimental Science Department (CEXS), has identified the receptors involved in triggering the cytotoxic activity of human NK (natural killer) cells in response to human cytomegalovirus (HCMV)-infected dendritic cells.

  Més informació "Important progress made on the human immune system’s ability to tackle cytomegalovirus"

• 16/11/2010 - Press release

  Benign skin tumours provide clues to the molecular mechanisms involved in cancer

  

  A study jointly led by researchers from the Hospital del Mar and the IMIM in Barcelona, Regensburg University (Germany) and the Epithelial Carcinogenesis group of the Molecular Pathology Programme at the National Centre for Cancer Research (CNIO, Centro Nacional de Investigaciones Oncológicas) has explained new aspects regarding the genetics of benign skin tumours which question how tumours develop and progress.

  Més informació "Benign skin tumours provide clues to the molecular mechanisms involved in cancer"

• 16/11/2010 - Press release

  Jordi Sunyer has been awarded the Advanced Grant for scientific excellence

  

  One of the grants awarded by the European Research Council (ERC) this year was for the BREATHE (BRain dEvelopment and Air polluTion ultrafine particles in scHool ChildrEn) project directed by Dr. Jordi Sunyer, co-director of the Research Centre for Environmental Epidemiology (CREAL) and director of the IMIM Research Programme in Epidemiology and Public Health.

  Més informació "Jordi Sunyer has been awarded the Advanced Grant for scientific excellence"

• 08/11/2010 - Press release

  A new treatment option for fighting obesity has been identified

  

  A study in Barcelona led by Dr. Silvia Delgado of the Hospital del Mar Digestion Service and IMIM researcher at the Hospital del Mar Research Institute, shows that speeding up the arrival of nutrients into the intestine with a drug manages to reduce the amount of food consumed in one meal. These results have been published in the International Journal of Obesity and involve a change of paradigm with regard to the established knowledge on the mechanisms which control satiety and ingestion in humans.

  Més informació "A new treatment option for fighting obesity has been identified"

• 2nd november 2010 - Institutional news

  European science journalists visit the IMIM

  

  A group of science journalists from the European Union of Science Journalists Associations (EUSJA) visited the PRBB last Wednesday October 27. They came from Belgium, Czech Republic, Finland, Germany, Hungary, Italy, Netherlands, Russia, Sweden and the United Kingdom. During a couple of hours the journalists visited the building and some of the facilities and they also had a chance to talk to some researchers, such as en Manolis Kogevinas (CREAL), Anna Bigas (IMIM) or Maria José Barrero (CMRB) about the research taking place in their centres.

  Més informació "European science journalists visit the IMIM"

• 25/10/2010 - Press release

  A multi-stage genome-wide association study of bladder cancer identifies several new susceptibility loci

  

  A large collaborative multi-stage study led by the US National Cancer NCI and based on the Spanish Bladder Cancer (SBCS) / EPICURO Study jointly coordinated by Spanish National Cancer Research Centre (CNIO) and the Centre de Recerca en Epidemiologia Ambiental (CREAL) and IMIM, has identified several new genetic variants associated with bladder cancer risk and validated recently reported variants.

  Més informació "A multi-stage genome-wide association study of bladder cancer identifies several new susceptibility loci"

• 19/10/2010 - Press release

  Diseases considered as mild most affect a country’s productivity

  

  Days of absence due to illness are the main source of lost human capital for a country’s economy. A paper led by researchers from the IMIM Health Services Research Group (Hospital del Mar Research Institute), has studied what mental and physical disorders occur most commonly and account for days of absence from the usual daily activity.

  Més informació "Diseases considered as mild most affect a country’s productivity"